38 results
Page 2 of 2
8-K
EX-99.1
muoqz1oq2rfl 048
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.1
zkxaaiin ak9rnh2f8s
8 Jan 21
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
xzt2y3sxl3kwxrxkgl96
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-99.1
g5hcikn7zzjlb2cf86q
2 Sep 20
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
8:57am
8-K
EX-99.1
xfriyweh
26 May 20
NeuroBo Pharmaceuticals Announces Continuation of Partial
8:39am
8-K
EX-99.1
60r8em7p
13 Jan 20
Regulation FD Disclosure
3:11pm
8-K
EX-99.3
gnppml 25yxj
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
8-K
EX-10.6
0j7ong38
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
425
EX-10.6
vgp1f9xc7qb orq48u
25 Jul 19
Business combination disclosure
6:36am
425
EX-99.3
4j162mldxdk
25 Jul 19
Business combination disclosure
6:36am
8-K
EX-99.1
2xhmfbxmnh jf
8 Nov 18
Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
nzg ztalw0wp1ib0gj
13 Aug 18
Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
5:01pm
8-K
EX-99.1
vze16vd6impu8
6 Aug 18
Gemphire Provides Update On Development of Gemcabene
4:01pm
8-K
EX-99.2
tuhw98qhcyg8 oyya8cg
28 Jun 18
ADVANCING CARDIOVASCULAR AND NASH OPPORTUNITIES INDIGO-1 Trial Top-Line Results June 28th, 2018
4:30pm
10-K
ckbf9gsxpta
21 Mar 17
Annual report
12:00am